This invention generally relates to the derivatives of novel 3,6 disubstituted azabicyclo[3.1.0] hexane's. The compounds of this invention are MUSCARINIC receptor antagonists which are useful, inter-ail for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through MUSCARINIC receptors. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through MUSCARINIC receptors.
本发明通常涉及新型3,6二取代的氮杂
双环[3.1.0]己烷的衍
生物。本发明的化合物是MUSCARINIC受体拮抗剂,可用于治疗通过MUSCARINIC受体介导的呼吸系统、泌尿系统和胃肠系统的各种疾病,因此在医学上具有广泛应用。本发明还涉及制备本发明化合物的方法、含有本发明化合物的制药组合物以及治疗通过MUSCARINIC受体介导的疾病的方法。